The Phenotypes of Multiple Sclerosis Differ Significantly in Relative and Excess Mortality
European Journal of Neurology · 2025
DOI: 10.1111/ene.70122 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Neurology, 2025. Verfasst von Melinda Magyari und 2 weiteren Autor:innen. Beteiligte Einrichtung: The Danish Multiple Sclerosis Registry, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Multiple Sclerosis, Chronic Progressive, Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Patients With Multiple Sclerosis ( MS ) Have Higher Mortality Than Matched Background Populations. We Compare Relative and Excess Mortality in MS Over the Matched Background Populations Between Primary Progressive MS ( PPMS ), relapsing Onset MS ( ROMS ), and Secondary Progressive MS ( SPMS ).
Methods
We included all patients from the nationwide and complete Danish MS Registry with onset 1994–2022 and compared the extra mortality of the MS phenotypes in terms of relative and excess mortality, with adjustment for sex, age at onset, disease‐modifying treatment, and number of recorded relapses. We calculated the adjusted ratios of relative and excess mortalities between PPMS and ROMS and between PPMS and SPMS.
Results
The initial course was unknown in 221, leaving 1412 cases with PPMS (which includes progressive relapsing MS) and 12,449 cases with ROMS. 627 had died during follow‐up by the end of 2022. After adjustment, both ratios between PPMS and ROMS came close to unity, indicating that the excess mortality is equal for PPMS and ROMS in the long run. The adjusted relative and additive mortalities were factors 6.05 (95% CI 4.42–8.27) and 1.90 (95% CI 1.65–2.18) higher in SPMS than in PPMS.
Conclusions
Compared with the matched population, the adjusted relative and excess mortalities are the same for PPMS and ROMS. However, SPMS had a higher relative and excess mortality than PPMS, probably in part owing to the burden of disease carried over from the pre‐progressive phase. This underlines the need for effective treatment in this later stage of the disease and more attention to comorbidity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Danish Multiple Sclerosis Registry, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.
- Danish Multiple Sclerosis Center, Department of Neurology, Copenhagen University Hospital-Rigshospitalet, Glostrup, Denmark.
- Institute for Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
- Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark.
Zitieren
APA
Magyari, M., Elberling, F., & Koch-Henriksen, N. (2025). The Phenotypes of Multiple Sclerosis Differ Significantly in Relative and Excess Mortality. European Journal of Neurology. https://doi.org/10.1111/ene.70122
Vancouver
Magyari M, Elberling F, Koch-Henriksen N. The Phenotypes of Multiple Sclerosis Differ Significantly in Relative and Excess Mortality. European Journal of Neurology. 2025. doi:10.1111/ene.70122
BibTeX
@article{Magyari2025,
author = {Magyari, Melinda and Elberling, Frederik and Koch-Henriksen, Nils},
title = {The Phenotypes of Multiple Sclerosis Differ Significantly in Relative and Excess Mortality},
journal = {European Journal of Neurology},
year = {2025},
doi = {10.1111/ene.70122}
}
EUVIMED